|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/06 | |
| A61K 31/506 | |||
| A61K 31/505 | |||
| A61P 25/22 | |||
| A61P 25/00 |
| (11) | Number of the document | 3345902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18155385.0 |
| Date of filing the European patent application | 2014-03-06 | |
| (97) | Date of publication of the European application | 2018-07-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361786288 P | 2013-03-14 | US |
| (72) |
BOLLU, Venkataiah, US
BREITENBUCHER, James, US
KAPLAN, Alan, US
LEMUS, Robert, US
LINDSTROM, Andrew, US
VICKERS, Troy, US
WILSON, Mark E., US
ZAPF, James, US
WEINHOUSE, Michael I., US
|
| (73) |
Dart Neuroscience (Cayman) Ltd.,
10 Market Street, No. 774 Camana Bay, Grand Cayman, KY1-9006,
KY
|
| (54) | SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS |
| SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS |